Biopharmaceutical R&D Working to Fight COVID-19

America’s biopharmaceutical companies turned a once in a generation challenge into reality by delivering safe and effective COVID-19 vaccines and treatments to patients in record time.

Learn About Member Efforts
See Our Treatment Progress
Browse Resources

PhRMA COVID-19 Treatment Progress

Browse the Data

COVID-19 Vaccinations

Unicef.org Data as of: May 9, 2022, Posted: May 9, 2022 6:00 PM ET

NYTimes Data as of: May 9, 2022. Posted: May 9, 2022 6:00 PM ET

14B

doses delivered

Globally

Unicef

11.7B

Doses administered

Globally

New York Times

578.2M

Doses Administered

United States

New York Times

Read the Latest on COVID Research and Development

Navigating the patient experience in the time of COVID-19

by Cynthia Hicks

Global COVID-19 vaccination matters now and for the future

by Anne McDonald Pritchett, PhD

Understanding breakthrough COVID-19 infections

by Richard Moscicki, M.D.

PhRMA submission to 2022 National Trade Estimate Report

by Douglas Petersen